The global market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services was valued at US$ 6476 million in the year 2024 and is projected to reach a revised size of US$ 16230 million by 2031, growing at a CAGR of 14.2% during the forecast period.
Developing, optimising, and manufacturing Advanced Therapy Medicinal Products (ATMP鈥檚), such as Cell and Gene Therapy (CGT) products is extremely complex. The choice of a reliable Contract Development Manufacturing Organisation (CDMO) is one of the most critical steps determining your product鈥檚 future.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services.
The Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AGC Biologics
BlueReg
Bio Elpida
Celonic
CGT Catapult
Catalent
Cellipont Bioservices
Lonza
Minaris Regenerative Medicine
Patheon
Rentschler Biopharma SE
Recipeharm
WuXi Advanced Therapies
Segment by Type
Gene Therapy
Cell Therapy
Tissue Engineered
Others
Segment by Application
Oncology
Cardiology
Central Nervous System
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Therapy
1.2.3 Cell Therapy
1.2.4 Tissue Engineered
1.2.5 Others
1.3 Market by Application
1.3.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Central Nervous System
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Perspective (2020-2031)
2.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Growth Trends by Region
2.2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Historic Market Size by Region (2020-2025)
2.2.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecasted Market Size by Region (2026-2031)
2.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Dynamics
2.3.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Trends
2.3.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Drivers
2.3.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Challenges
2.3.4 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Players by Revenue
3.1.1 Global Top Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Players by Revenue (2020-2025)
3.1.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share by Players (2020-2025)
3.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue
3.4 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Concentration Ratio
3.4.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue in 2024
3.5 Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Head office and Area Served
3.6 Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, Product and Application
3.7 Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Breakdown Data by Type
4.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Historic Market Size by Type (2020-2025)
4.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecasted Market Size by Type (2026-2031)
5 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Breakdown Data by Application
5.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Historic Market Size by Application (2020-2025)
5.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)
6.2 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025)
6.4 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)
7.2 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025)
7.4 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)
8.2 Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)
9.2 Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025)
9.4 Latin America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size (2020-2031)
10.2 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AGC Biologics
11.1.1 AGC Biologics Company Details
11.1.2 AGC Biologics Business Overview
11.1.3 AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.1.4 AGC Biologics Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.1.5 AGC Biologics Recent Development
11.2 BlueReg
11.2.1 BlueReg Company Details
11.2.2 BlueReg Business Overview
11.2.3 BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.2.4 BlueReg Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.2.5 BlueReg Recent Development
11.3 Bio Elpida
11.3.1 Bio Elpida Company Details
11.3.2 Bio Elpida Business Overview
11.3.3 Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.3.4 Bio Elpida Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.3.5 Bio Elpida Recent Development
11.4 Celonic
11.4.1 Celonic Company Details
11.4.2 Celonic Business Overview
11.4.3 Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.4.4 Celonic Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.4.5 Celonic Recent Development
11.5 CGT Catapult
11.5.1 CGT Catapult Company Details
11.5.2 CGT Catapult Business Overview
11.5.3 CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.5.4 CGT Catapult Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.5.5 CGT Catapult Recent Development
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.6.4 Catalent Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.6.5 Catalent Recent Development
11.7 Cellipont Bioservices
11.7.1 Cellipont Bioservices Company Details
11.7.2 Cellipont Bioservices Business Overview
11.7.3 Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.7.4 Cellipont Bioservices Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.7.5 Cellipont Bioservices Recent Development
11.8 Lonza
11.8.1 Lonza Company Details
11.8.2 Lonza Business Overview
11.8.3 Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.8.4 Lonza Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.8.5 Lonza Recent Development
11.9 Minaris Regenerative Medicine
11.9.1 Minaris Regenerative Medicine Company Details
11.9.2 Minaris Regenerative Medicine Business Overview
11.9.3 Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.9.4 Minaris Regenerative Medicine Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.9.5 Minaris Regenerative Medicine Recent Development
11.10 Patheon
11.10.1 Patheon Company Details
11.10.2 Patheon Business Overview
11.10.3 Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.10.4 Patheon Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.10.5 Patheon Recent Development
11.11 Rentschler Biopharma SE
11.11.1 Rentschler Biopharma SE Company Details
11.11.2 Rentschler Biopharma SE Business Overview
11.11.3 Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.11.4 Rentschler Biopharma SE Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.11.5 Rentschler Biopharma SE Recent Development
11.12 Recipeharm
11.12.1 Recipeharm Company Details
11.12.2 Recipeharm Business Overview
11.12.3 Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.12.4 Recipeharm Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.12.5 Recipeharm Recent Development
11.13 WuXi Advanced Therapies
11.13.1 WuXi Advanced Therapies Company Details
11.13.2 WuXi Advanced Therapies Business Overview
11.13.3 WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Introduction
11.13.4 WuXi Advanced Therapies Revenue in Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Business (2020-2025)
11.13.5 WuXi Advanced Therapies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
AGC Biologics
BlueReg
Bio Elpida
Celonic
CGT Catapult
Catalent
Cellipont Bioservices
Lonza
Minaris Regenerative Medicine
Patheon
Rentschler Biopharma SE
Recipeharm
WuXi Advanced Therapies
听
听
*If Applicable.
